These cells are used for subsequent transplantation to enhance marrow regeneration. Because therapeutic procedures are controversial and not without risk, clinicians must get approval from the apheresis center medical director before patients are scheduled. See Chapter 8. Any such request to the Blood Bank must be documented in writing and approved by the Blood Bank Director. The phlebotomy may be done in a donor room setting, but more often it is done in a hospital setting.
Policy varies with institution.
If the blood does meet allogeneic transfusion requirements, it may only be used if it is fully tested, the label specifies the therapeutic bleed and donor disease, and the Blood Bank Director and recipient's physician both agree to its use. American Association of Blood Banks, Bethesda, MD, 1994. AABB Technical Manual, 11th edition. American Association of Blood Banks, Bethesda, MD, 1993. Autologous and Designated Donor Programs.